Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

A phase 2 study showed that giving maintenance regorafenib could delay disease progression in patients with non-adipocytic ...

When 'fit and healthy' Kate Drummond began experiencing back pain, doctors misdiagnosed her with sciatica, not realising that ...

Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different ...

In solid tumors, such as skin, lung, or bone and soft tissue cancer (sarcomas), they have not yet proven themselves as a treatment method. Tumor shrinkage was achieved only in rare cases ...

Not much is known about this difficult disease sarcoma cancer because it is easy to ignore the small lumps in the beginning ...

Osaka Metropolitan University-led researchers verified the therapeutic effects of plasma-activated medium on synovial sarcoma ...